Intellia Therapeutics was founded in 2014 by Caribou Biosciences and Atlas Venture, along with a consortium of leading scientists who have helped define the space. Intellia Therapeutics holds exclusive access to a broad intellectual property portfolio covering the application of CRISPR/Cas9 technology for human therapeutic use. As we build our team, we’re looking for people who share our commitment and energy to make a difference. See our current openings below.
TITLE: Computational Biologist/Bioinformatician
TITLE: Research Scientist I, Hematopoietic Stem Cell Biology
TITLE: Research Associate, Screening & Molecular Biology
TITLE: Senior Research Associate, Ex Vivo Biology
Post expires at 1:02pm on Thursday January 19th, 2017